Hashad Mohamed Wa'el Ahmed — SEC Form 4 filings
SEC reporting owner CIK 1966752. 11 Form 4 filings on record with FilingPulse; latest filed 2025-07-17.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-25 to 2025-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,638 shares, $24,999 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 10,638 shares @ $2.35 ($24,999) in Longeveron Inc., filed 2024-04-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Longeveron Inc. (LGVN) | Chief Executive Officer | 10 | 1 leg · 10,638 sh · $24,999 | — | 14 |
| Akari Therapeutics Plc (AKTX) | Director | 1 | — | — | 1 |
Form 4 filings — Hashad Mohamed Wa'el Ahmed
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-17 | 4 | Longeveron Inc. (LGVN) | Grant/award (A): 180,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Longeveron Inc. (LGVN) | Tax withholding (F): 13,146 @ $1.28 | EDGAR |
| 2025-04-03 | 4 | Longeveron Inc. (LGVN) | Tax withholding (F): 13,384 @ $1.50 | EDGAR |
| 2025-01-06 | 4 | Longeveron Inc. (LGVN) | Tax withholding (F): 10,827 @ $1.79 | EDGAR |
| 2024-10-03 | 4 | Longeveron Inc. (LGVN) | Tax withholding (F): 13,357 @ $1.88 | EDGAR |
| 2024-08-19 | 4 | Longeveron Inc. (LGVN) | Grant/award (A): 311,250 @ $0 · Tax withholding (F): 39,248 @ $2.46 · Grant/award (A): 28,750 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 5,000,000 (derivative) @ $0 | EDGAR |
| 2024-04-12 | 4 | Longeveron Inc. (LGVN) | Purchase (P): 10,638 @ $2.35 · Purchase (P): 10,638 (derivative) @ $0.12 | EDGAR |
| 2024-03-20 | 4 | Longeveron Inc. (LGVN) | Grant/award (A): 80,200 @ $0 · Tax withholding (F): 32,866 @ $0.54 | EDGAR |
| 2024-02-02 | 4 | Longeveron Inc. (LGVN) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Longeveron Inc. (LGVN) | Tax withholding (F): 5,123 @ $1.32 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1966752 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →